Provided by Tiger Trade Technology Pte. Ltd.

Quasi-New Stocks

693.03
+4.110.60%
Number of Gainers:71
Number of Losers:69
Number of Flat:14
PE:- -
High:698.21
Open:689.82
Low:685.07
Close:688.92
Volume:272.16M
Turnover:8.90B
Market Cap:479.85B
Float Cap:365.12B

Loading ...

Spyre Therapeutics announces 12-week induction data from Part A of SKYLINE trial

TIPRANKS
·
Sep 08

BofA Securities Adjusts Torrid Price Target to $2.70 From $2.25

MT Newswires Live
·
Sep 08

Mobix Labs Secures Initial F-16 Component Order, Expanding U.S. Fighter Aircraft Footprint

THOMSON REUTERS
·
Sep 08

FTC Solar Starts Shipments for 330-MW Fraser Coast Project in Australia

Reuters
·
Sep 08

Rani Therapeutics Management to Attend Lake Street BIG10 Growth Conference

Reuters
·
Sep 08

Phillips Edison & Company to Participate in Webcast Panel at Barclays 24th Annual Financial Services Conference

GlobeNewswire
·
Sep 08

Paymentus Study Flags $330 Billion Annual Service Bill Revenue at Risk from Billing Friction

Reuters
·
Sep 08

Aurora Networks, Vistance Networks Unit, Deploys Kaltura Cloud TV Platform at Bouygues Telecom

Reuters
·
Sep 08

Robinhood Strikes Deal with Crypto.com in Latest Prediction-Markets Push- WSJ

THOMSON REUTERS
·
Sep 08

Robinhood Will Add Yes-or-no Contracts from Crypto.com Prediction Business and Take Stake in Digital-Currency Exchange- WSJ

THOMSON REUTERS
·
Sep 08

【US Pre-Market】Middle East Energy Risks Escalate, Brent Crude Nears $100, Oil and Gas Stocks Rise; Novartis Plunges 13%

TradingKey
·
Sep 08

Upexi to Participate in FT Partners FinTech Conference 2026 on September 15th

GlobeNewswire
·
Sep 08

Rani Therapeutics to Participate in Upcoming September Conferences

GlobeNewswire
·
Sep 08

Climb Bio is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
Sep 08

Analysts Offer Insights on Technology Companies: Shopify (SHOP) and UiPath (PATH)

TIPRANKS
·
Sep 08

Robinhood Markets Price Target Raised to $150.00/Share from $115.00 by Cantor Fitzgerald

Dow Jones
·
Sep 08

Absci price target raised to $15 from $13 at BTIG

TIPRANKS
·
Sep 08

Monte Rosa Therapeutics to receive $50M milestone payment from Novartis

TIPRANKS
·
Sep 08

Monte Rosa Says Novartis Starts Phase 2 Trial of MRT-6160 in Sjögren's Disease, Triggers USD 50 Million Milestone

Reuters
·
Sep 08

Monte Rosa Therapeutics Announces Milestone Achievement Associated with Initiation of Phase 2 Clinical Study for Vav1-Directed Molecular Glue Degrader Mrt-6160 (Ddy391)

THOMSON REUTERS
·
Sep 08